{"name":"Universidad Abierta Interamericana","slug":"universidad-abierta-interamericana","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dextrose 5% (D5W)","genericName":"Dextrose 5% (D5W)","slug":"dextrose-5-d5w","indication":"Fluid and electrolyte replacement in dehydration","status":"marketed"}]}],"pipeline":[{"name":"Dextrose 5% (D5W)","genericName":"Dextrose 5% (D5W)","slug":"dextrose-5-d5w","phase":"marketed","mechanism":"Dextrose 5% provides a source of glucose and water for intravenous fluid replacement and caloric supplementation.","indications":["Fluid and electrolyte replacement in dehydration","Maintenance therapy in patients unable to take oral intake","Provision of calories and hydration in perioperative and critical care settings"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}